Treatment outcomes of intravitreal ranibizumab for diabetic macular oedema in vitrectomised eyes

被引:0
|
作者
Lu, Vicky Hsin-Ju [1 ]
Antao, Sheelah [1 ]
Fajgenbaum, Mark [1 ,2 ]
Wong, Roger [2 ]
Bainbridge, James W. B. [1 ]
da Cruz, Lyndon [1 ]
Hamilton, Robin D. [1 ]
Rajendram, Ranjan [1 ]
机构
[1] Moorfields Eye Hosp NHS Trust, Med Retina, London, England
[2] Kings Coll London, Dept Ophthalmol, St Thomas Hosp Campus, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2095
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Comparison of Modified Grid Laser & Intravitreal Ranibizumab, and Mild Macular Laser & Intravitreal Ranibizumab in the Treatment of Diabetic Macular Edema
    Guzey, Mustafa
    Adibelli, Fatih Mehmet
    Altun, Gonul
    OPHTHALMOLOGICA, 2014, 232 : 14 - 15
  • [32] Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes with Diabetic Macular Edema
    Srinivas, Sowmya
    Verma, Aditya
    Nittala, Muneeswar G.
    Alagorie, Ahmed Roshdy
    Nassisi, Marco
    Gasperini, Julie
    Sadda, Srinivas R.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 211 : 183 - 190
  • [33] Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting
    Brynskov, Troels
    Laugesen, Caroline Schmidt
    Sorensen, Torben Lykke
    ACTA OPHTHALMOLOGICA, 2013, 91 (03) : E243 - E244
  • [34] Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
    Wang, Jia-Kang
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Ho, Wei-Ting
    Hsu, Yung-Ray
    Chen, Fang-Ting
    Chen, Yun-Ju
    JOURNAL OF OPHTHALMOLOGY, 2021, 2021
  • [35] Effect of intravitreal ranibizumab on intraretinal hard exudates in eyes with diabetic macular edema
    Srinivas, Sowmya
    Nittala, Muneeswar Gupta
    Gasperini, Julie
    Sadda, Srinivas R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [36] Intravitreal (IVT) ranibizumab injections for diabetic macular oedema (DMO): real world results
    Mourtzoukos, Spyridon
    EYE, 2017, 31 : S13 - S13
  • [37] Comparison of the Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema in Vitrectomized and Nonvitrectomized Eyes
    Koyanagi, Yoshito
    Yoshida, Shigeo
    Kobayashi, Yoshiyuki
    Kubo, Yuki
    Yamaguchi, Muneo
    Nakama, Takahito
    Nakao, Shintaro
    Ikeda, Yasuhiro
    Ohshima, Yuji
    Ishibashi, Tatsuro
    Sonoda, Koh-hei
    OPHTHALMOLOGICA, 2016, 236 (02) : 67 - 73
  • [38] Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes
    Puche, Nathalie
    Glacet, Agnes
    Mimoun, Gerard
    Zourdani, Alain
    Coscas, Gabriel
    Soubrane, Gisele
    ACTA OPHTHALMOLOGICA, 2012, 90 (04) : 357 - 361
  • [39] Ranibizumab and diabetic macular oedema (DMO): a retrospective review of patient outcomes
    Nicholson, E. J.
    Bujanova, J.
    Cranston, I. C. P.
    Cansfield, J.
    Mourtzoukos, S.
    DIABETOLOGIA, 2016, 59 : S478 - S478
  • [40] Real-world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008-2021
    Lindboe, Johanne Bjerre
    Brynskov, Troels
    Sorensen, Torben Lykke
    Laugesen, Caroline Schmidt
    ACTA OPHTHALMOLOGICA, 2024, 102 (04) : e661 - e662